Condition

Tumor Immunity clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• 68Ga-CD73 PET/CT imaging for diagnosing malignant tumors

  This uses a 68Ga-DOTA-dPNE PET/CT scan that targets CD73 to see if it can detect malignant tumors and help predict response to targeted therapies in adults with measurable solid tumors.

  Recruiting Peking Union Medical College Hospital · Dongcheng, Beijing Municipality · NCT06844110

• Combining radiofrequency ablation with carrizumab for advanced liver cancer

  This study tests if adding a heat treatment called radiofrequency ablation to a new drug, carrizumab, can help people with advanced liver cancer live longer without their cancer getting worse compared to just using carrizumab alone.

  Recruiting Phase 2 Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT04150744

Related topics

Quick answers

How many Tumor Immunity clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →